Stockreport

Cortexyme’s Atuzaginstat Slowed Cognitive Decline in Participants With Alzheimer’s Disease and P. Gingivalis Infection in Phase 2/3 GAIN Trial: Additional Top-line Data Presented at CTAD 2...

Cortexyme, Inc.  (CRTX) 
PDF Evidence supports P. gingivalis as a driver of Alzheimer’s in easily identified patient populationSuccessful identification of target population and therapeutic dose inf [Read more]